| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...733003T |
| P356 | DOI | 10.1371/JOURNAL.PONE.0033003 |
| P932 | PMC publication ID | 3296775 |
| P698 | PubMed publication ID | 22412972 |
| P5875 | ResearchGate publication ID | 221698736 |
| P50 | author | Emily A Vucic | Q43585150 |
| Calum E MacAulay | Q63468497 | ||
| P2093 | author name string | Wei Zhang | |
| Pei Wang | |||
| Adi F Gazdar | |||
| Ziding Feng | |||
| Rong Fu | |||
| William W Lockwood | |||
| Stephen Lam | |||
| John C English | |||
| Kelsie L Thu | |||
| Raj Chari | |||
| Wan L Lam | |||
| P2860 | cites work | Lung cancer in never smokers: clinical epidemiology and environmental risk factors | Q24598433 |
| A small-cell lung cancer genome with complex signatures of tobacco exposure | Q24600510 | ||
| Characterizing the cancer genome in lung adenocarcinoma | Q24649926 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| Lung cancer in never smokers: a review | Q28287500 | ||
| Genomic aberrations in lung adenocarcinoma in never smokers | Q28385032 | ||
| The UCSC Genome Browser database: update 2010 | Q29614173 | ||
| Lung cancer in never smokers--a different disease | Q29615414 | ||
| Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma | Q30014823 | ||
| Resolving the resolution of array CGH. | Q33271882 | ||
| Finding exclusively deleted or amplified genomic areas in lung adenocarcinomas using a novel chromosomal pattern analysis | Q33481331 | ||
| Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells | Q33510334 | ||
| FACADE: a fast and sensitive algorithm for the segmentation and calling of high resolution array CGH data | Q33605550 | ||
| Integrated mutation, copy number and expression profiling in resectable non-small cell lung cancer. | Q33840094 | ||
| New driver mutations in non-small-cell lung cancer | Q34161395 | ||
| Lung cancer in never smokers: molecular profiles and therapeutic implications | Q34177155 | ||
| Chromosome aberrations in solid tumors | Q35201471 | ||
| Mitochondrial DNA mutations in respiratory complex-I in never-smoker lung cancer patients contribute to lung cancer progression and associated with EGFR gene mutation | Q35667130 | ||
| Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer. | Q36614403 | ||
| Smoking-related genomic signatures in non-small cell lung cancer | Q37287242 | ||
| An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors | Q37294205 | ||
| EGFR mutations and lung cancer | Q37795807 | ||
| Genomic profiles specific to patient ethnicity in lung adenocarcinoma | Q39756938 | ||
| Integrative genomic and gene expression analysis of chromosome 7 identified novel oncogene loci in non-small cell lung cancer | Q39904378 | ||
| Primary adenocarcinomas of the lung in nonsmokers show a distinct pattern of allelic imbalance. | Q53388017 | ||
| The genesis and evolution of high-grade serous ovarian cancer | Q55053523 | ||
| Chromosomal aberrations of primary lung adenocarcinomas in nonsmokers | Q73031848 | ||
| Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers | Q73603262 | ||
| Patterns of allelic loss differ in lung adenocarcinomas of smokers and nonsmokers | Q78709816 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | e33003 | |
| P577 | publication date | 2012-03-07 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability | |
| P478 | volume | 7 |
| Q57125214 | A network-based signature to predict the survival of non-smoking lung adenocarcinoma |
| Q35429274 | A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targets |
| Q28390823 | An integrated inspection of the somatic mutations in a lung squamous cell carcinoma using next-generation sequencing |
| Q40259346 | Assessment of the clinical relevance of 17q25.3 copy number and three-dimensional telomere organization in non-small lung cancer patients |
| Q64075360 | Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients |
| Q40675065 | Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinoma |
| Q36741251 | EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancer |
| Q35924241 | EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk |
| Q48240221 | Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing |
| Q51601238 | Gene Therapy for Lung Cancer. |
| Q33947935 | Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers |
| Q41513953 | Impact of smoking on outcome of resected lung adenocarcinoma |
| Q90715196 | Integrative Genomic Analyses Identifies GGA2 as a Cooperative Driver of EGFR-Mediated Lung Tumorigenesis |
| Q43889503 | Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer. |
| Q38669282 | KRAS-Mutant Lung Cancers in the Era of Targeted Therapy |
| Q59791995 | Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome |
| Q33888782 | Loss of tumour-specific ATM protein expression is an independent prognostic factor in early resected NSCLC. |
| Q34429985 | Lung cancer transcriptomes refined with laser capture microdissection |
| Q35957598 | Microtubule affinity-regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non-small cell lung cancer. |
| Q26828860 | Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors |
| Q34159011 | Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular |
| Q47402801 | Never smokers with resected lung cancer: different demographics, similar survival |
| Q33649020 | Oncogenomic disruptions in arsenic-induced carcinogenesis |
| Q58804393 | Preface: lung cancer in never smokers |
| Q38993492 | Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions. |
| Q34436424 | Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology |
| Q38103187 | The detection and implication of genome instability in cancer |
| Q38041993 | Transcriptome alterations induced by cigarette smoke |
| Q28388931 | Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention |
| Q38594037 | Variation in KRAS driver substitution distributions between tumor types is determined by both mutation and natural selection. |
| Q38113540 | Worldwide trend of increasing primary adenocarcinoma of the lung |
| Q34653749 | miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells |
Search more.